Resource Center
Resource Center
Demand-Driven Evaluations for Decisions (3DE) is a pioneering approach to support ministries of health with evidence-based decision-making by using rigorous impact evaluations in a demand-driven, rapid, and efficient way. Learn more about the 3DE approach in this program overview.
Read moreView the Clinton Health Access Initiative, Inc. and Subsidiaries' Consolidated Financial Statements for 2014.
Read moreMalaria rapid diagnostic tests (RDTs) are an effective tool for confirming true malaria cases in resource-limited settings, yet are often unavailable in the private sector where many seek treatment. CHAI worked with global manufacturers and importers in Tanzania’s private sector to reduce the price of RDTs. To date, 2.1 million tests have been sold and...
Read moreIn small northern Nigerian villages such as Bukka, 56 miles southeast of Kano City, health workers walk dusty paths under the searing heat of the tropical afternoon carrying lifesaving malaria drugs to children. Often, they work past sunset to ensure that they administer the drugs to as many eligible children as possible in a day....
Read moreIn July 2014, CHAI and partners began work to implement a comprehensive Maternal and Newborn Health (MNH) program aimed at improving maternal and newborn health outcomes in the States of Kano, Katsina and Kaduna, northern Nigeria. A component of the program aims to strengthen emergency transport systems between rural communities and primary health care facilities...
Read moreThe 2014 Annual Report highlights CHAI’s programmatic work around the world, thanks to our many dedicated partners and supporters.
Read moreTreating severe malaria with injectable artesunate instead of quinine can substantially reduce mortality. To increase uptake and improve health outcomes, CHAI supported ministries of health in six high-burden countries to overcome barriers to adoption. Learn more about CHAI’s work to increase update and reduce severe malaria mortality in this case study.
Read moreAccess to better tolerated, more convenient regimens for HIV treatment promotes adherence and leads to better patient outcomes. CHAI is working to ensure affordable pricing and to address demand-side barriers to access. Increased uptake of optimal second-line regimens in Uganda and Nigeria has improved HIV treatment and will deliver US$6.5 million in savings by 2018....
Read moreCHAI and partners achieved a price reduction agreement for contraceptive implants that increased total implant distribution by 56 percent from 2012 to 2013 and will result in procurement savings of more than US$300 million over six years. Learn more about this agreement to expand access to contraceptive implants and improve women’s choice and well-being in...
Read moreAchieving universal access to HIV treatment requires using the resources available as efficiently as possible. To this end, CHAI supports 10 countries to conduct annual resource mapping. In Malawi, results have informed the allocation of US$300 million to high-impact interventions and increased national ownership of the HIV response. Learn more about CHAI’s work improving efficiency...
Read more